Insights from 2024 ASCO® GI Annual Meeting
Playback speed
10 seconds
ASCO® GI 2024 Insights: "FRESCO-2 trial - Quality-Adjusted Time Without Symptoms of Disease or Toxicity Analysis of Fruquintinib + BSC Compared With Placebo + BSC in mCRC"
150 views
January 31, 2024
Comments 0
Login to view comments.
Click here to Login
Videos